✉news BusinessStartups first seen 6 h ago, last 1 h ago, peak #15
Immunology startup TRex Bio sets terms for $133 million IPO
Original: Immunology startup TRex Bio sets price range for $133 million public debut
Immunology startup TRex Bio has set a price range for an initial public offering expected to raise around $133 million. The company is developing therapies targeting immune-related diseases. The listing comes amid renewed interest in biotech debuts, with investors watching whether clinical-stage immunology companies can attract public market demand.
Why now: Biotech IPOs are drawing attention as market windows for new listings reopen and investors weigh clinical-stage immunology companies.
Rank over time, top of the chart is #1. 5 snapshots from 6 h ago to 1 h ago.
Evidence
- Immunology startup TRex Bio sets price range for $133 million public debut · Investing.com
- Immunology startup TRex Bio sets price range for $133 million public debut · Yahoo Finance
- Immunology startup TRex Bio sets price range for $133 million public debut · StreetInsider
API: https://socialmediatrends-api.osmike.com/v1/trends/1121577